The impact of [68Ga]PSMA I&T PET/CT on radiotherapy planning in patients with prostate cancer

Authors:

Abstract
To determine the impact of Gallium-68-labled prostate-specific membrane antigen positron-emission tomography/computed tomography ([68Ga]PSMA PET/CT) on radiotherapy planning for primary disease, biochemical cancer relapse, and advanced disease of prostate cancer.

This publication has 30 references indexed in Scilit: